#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Phaeochromocytoma Acute graft versus host disease in skin Transferrin decreased Idiopathic intracranial hypertension Renal disorder Encephalitis autoimmune Breast cancer Haemophilia Anti-HLA antibody test positive Osteopetrosis Synovial sarcoma recurrent Congenital megacolon Progressive multifocal leukoencephalopathy T-cell type acute leukaemia Idiopathic pulmonary fibrosis More trials…

    Learn about Rare Diseases

    Activated PI3 kinase delta syndrome – Life with Disease Brain stem glioma – Life with Disease Medulloblastoma recurrent – Basic Information Myxofibrosarcoma – Life with Disease Mucopolysaccharidosis III – Diagnostics Mantle cell lymphoma stage III – Trials in Disease Brain stem glioma Bronchiolitis obliterans syndrome – Life with Disease Ocular melanoma – Treatment Waldenstrom’s macroglobulinaemia refractory More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Andexanet Alfa Flortaucipir (18F) Sulfonamides, Urea Derivatives Livmoniplimab LY3537021 Terlipressin Acetate S227928 Suvecaltamide Roxithromycin ANTI-GD2-800CW POTASSIUM HYDROXIDE Etoricoxib Gandotinib Pelareorep GSKVX000000070965 Regn9933 Omp64 NALOXEGOL Cetirizine Elacestrant More therapies…

    Learn about Your Condition

    Partial seizures Chronic kidney disease Lysosomal storage disorder Pleomorphic leiomyosarcoma Pseudomyxoma peritonei Orthostatic hypotension Acne Cartilage injury Acute coronary syndrome B-cell type acute leukaemia Polycystic liver disease Neurotrophic keratopathy Immune-mediated myositis Carpal tunnel syndrome Pulmonary venous thrombosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Congenital, Hereditary, and Neonatal Diseases and Abnormalities

  • Study on Oral Propranolol for Preventing Severe Retinopathy in Premature Infants

    Recruiting

    2 1 1
    Investigated Diseases:
    • Retinopathy of prematurity
    Investigated Drugs:
    • Propranolol Hydrochloride
    Germany

  • Study on the Effects of ELGN-2112 (Human Insulin) for Treating Intestinal Malabsorption in Preterm Infants

    Recruiting

    3 1
    Investigated Diseases:
    • Malabsorption
    Investigated Drugs:
    • Insulin Human
    Austria France Italy The Netherlands Spain Sweden

  • A Study Testing Atumelnant Compared to Placebo in Adults with Classic Congenital Adrenal Hyperplasia to Reduce Steroid Dose While Controlling Hormones

    Recruiting

    3 1
    Investigated Diseases:
    • Adrenogenital syndrome
    Investigated Drugs:
    • ATUMELNANT
    Austria France Germany Italy The Netherlands Poland +1

  • Study on Long-Term Safety and Effects of Maralixibat for Patients with Alagille Syndrome

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Alagille syndrome
    Investigated Drugs:
    • MARALIXIBAT
    Belgium France Germany Italy The Netherlands Portugal +1

  • Efficacy and Safety of Daily Subcutaneous Elamipretide Trihydrochloride Injections in Patients with Barth Syndrome (Phase 3b/4 Randomized Trial)

    Not yet recruiting

    3 1
    Investigated Drugs:
    • Elamipretide Trihydrochloride
    France Ireland Italy The Netherlands

  • Study of Melpida with drug combination in patients with Hereditary Spastic Paraplegia Type 50 (SPG50)

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Meglumine Gadoterate
    • Sirolimus
    • Buclizine Hydrochloride
    Spain
Previous Page
1 … 17 18 19 20 21 … 45
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!